The effect of treatment with cytotoxic agents on mouse spleen dihydrofolate reductase activity.
D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology*; D005467:Floxuridine / Q000494:pharmacology*; D005492:Folic Acid / Q000494:pharmacology*; D066298:In Vitro Techniques; D002955:Leucovorin / Q000494:pharmacology*; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D051379:Mice; D009705:Nucleosides / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D013154:Spleen / Q000201:enzymology*; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism*; D013936:Thymidine / Q000494:pharmacology*
D009705:Nucleosides; D005467:Floxuridine; D003520:Cyclophosphamide; D005492:Folic Acid; D013762:Tetrahydrofolate Dehydrogenase; D002955:Leucovorin; D013936:Thymidine; D008727:Methotrexate